Education
About Us
Working with TipRanks
Follow Us
TG Therapeutics (TGTX)
NASDAQ:TGTX
Earnings Data
Report Date
Oct 30, 2025TBA (Confirmed)
Period Ending
2025 (Q3)Consensus EPS Forecast
0.22Last Year’s EPS
0.02Same Quarter Last Year
Based on 4 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call reflects a strong quarter for TG Therapeutics, marked by significant revenue growth, successful product adoption, and strategic pipeline advancements. However, increased operating expenses and potential market challenges are areas of concern.Company Guidance
Strong Revenue Growth
Total revenue for Q2 2025 was $141.1 million, including U.S. net product revenue of $138.8 million, representing a 91% increase compared to the same period last year and a 16% growth over the first quarter of this year.
Successful BRIUMVI Adoption
BRIUMVI is now prescribed to nearly 1 in every 3 new IV anti-CD20 patients, with significant growth in patient enrollments and new prescriber accounts.
Commercial Milestones
The company achieved the highest number of new patient enrollments since launch and launched a national television campaign to increase brand awareness.
Pipeline Progress
TG Therapeutics initiated a pivotal Phase III trial for subcutaneous BRIUMVI and dosed the first patient with progressive MS using azer-cel, an investigational CD19-directed CAR-T therapy.
TGTX Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
TGTX Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Aug 04, 2025 | $35.02 | $28.72 | -17.99% |
May 05, 2025 | $43.44 | $37.68 | -13.26% |
Mar 03, 2025 | $30.09 | $34.42 | +14.39% |
Nov 04, 2024 | $26.90 | $24.36 | -9.44% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does TG Therapeutics (TGTX) report earnings?
TG Therapeutics (TGTX) is schdueled to report earning on Oct 30, 2025, TBA (Confirmed).
What is TG Therapeutics (TGTX) earnings time?
TG Therapeutics (TGTX) earnings time is at Oct 30, 2025, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is TGTX EPS forecast?
TGTX EPS forecast for the fiscal quarter 2025 (Q3) is 0.22.